- Home
- XBIO vs NUWE Comparison
XBIO vs NUWE Comparison
Compare XBIO & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIO
- NUWE
- Stock Information
- Founded
- XBIO N/A
- NUWE 1999
- Country
- XBIO United States
- NUWE United States
- Employees
- XBIO N/A
- NUWE N/A
- Industry
- XBIO Biotechnology: Pharmaceutical Preparations
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- XBIO Health Care
- NUWE Health Care
- Exchange
- XBIO Nasdaq
- NUWE Nasdaq
- Market Cap
- XBIO 4.2M
- NUWE 3.9M
- IPO Year
- XBIO N/A
- NUWE N/A
- Fundamental
- Price
- XBIO $3.53
- NUWE $0.23
- Analyst Decision
- XBIO Hold
- NUWE Strong Buy
- Analyst Count
- XBIO 1
- NUWE 1
- Target Price
- XBIO N/A
- NUWE $17.00
- AVG Volume (30 Days)
- XBIO 169.6K
- NUWE 30.9M
- Earning Date
- XBIO 08-12-2025
- NUWE 08-12-2025
- Dividend Yield
- XBIO N/A
- NUWE N/A
- EPS Growth
- XBIO N/A
- NUWE N/A
- EPS
- XBIO N/A
- NUWE N/A
- Revenue
- XBIO $2,582,728.00
- NUWE $8,787,000.00
- Revenue This Year
- XBIO $14.23
- NUWE $6.53
- Revenue Next Year
- XBIO $7.14
- NUWE $51.63
- P/E Ratio
- XBIO N/A
- NUWE N/A
- Revenue Growth
- XBIO 5.63
- NUWE N/A
- 52 Week Low
- XBIO $2.20
- NUWE $0.21
- 52 Week High
- XBIO $5.27
- NUWE $6.61
- Technical
- Relative Strength Index (RSI)
- XBIO 58.63
- NUWE 26.12
- Support Level
- XBIO $2.65
- NUWE $0.21
- Resistance Level
- XBIO $5.27
- NUWE $0.32
- Average True Range (ATR)
- XBIO 0.45
- NUWE 0.07
- MACD
- XBIO 0.09
- NUWE 0.00
- Stochastic Oscillator
- XBIO 33.61
- NUWE 11.43
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.